-->

Member Access

Registration is free

Bookshelf

Kinase Drug Discovery (Rsc Drug Discovery)

by Richard A. Ward, Frederick Goldberg, David P. Rotella and David E. Thurston

KinaseInhBoook


Available in Dec 2011.

Visit our bookshelf for more books on Kinases and Kinase Inhibitors or pre-order this book today




B&W Powered

KKB Hot Article: Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells PDF Print E-mail
Written by KKB   
Tuesday, 20 April 2010 19:55
Citation: Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells
Authors: Choi SJ, Moon MJ, Lee SD, Choi SU, Han SY, Kim YC.
PubMed PMID: 20153646
Abstract: Indirubin derivatives were identified as potent FLT3 tyrosine kinase inhibitors with anti-proliferative activity at acute myeloid leukemic cell lines, RS4;11 and MV4;11 which express FLT3-WT and FLT3-ITD mutation, respectively. Among several 5 and 5'-substituted indirubin derivatives, 5-fluoro analog, 13 exhibited potent inhibitory activity at FLT3 (IC(50)=15 nM) with more than 100-fold selectivity versus 6 other kinases and potent anti-proliferative effect for MV4;11 cells (IC(50)=72 nM) with 30-fold selectivity versus RS4;11 cells. Cell cycle analysis indicated that compound 13 induced cell cycle arrest at G(0)/G(1) phase in MV4;11 cells.
Targets: AURKA,FLT3,KDR
Number of SAR data points: 49
Number of Targets: 3
Last Updated on Friday, 19 August 2011 23:25
 
Copyright © 2012 Kinase Data Portal. All Rights Reserved.
 

KinaseData Forum Latest Posts

No posts to display.

Featured Links:
Apple


B&W Powered

Fight Against Cancer